A bioequivalence study comparing two different strengths formulations of insulin lispro in patients with type 1 diabetes

Trial Identifier:	BEQ15846
Sponsor:	sanofi
Start Date:	March 2019
Primary Completion Date:	August 2019
Study Completion Date:	August 2019
Condition:	Diabetes: Type 1

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language	Description

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
Germany	Neuss, Germany, 41460

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.